Department of Psychiatry and Behavioral Sciences Archive — Page 4 of 12
-
September 2, 2021
White matter and schizophrenia
Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed. -
August 23, 2021
Estrogen, depression and menopause
A shift in emotional processing may help women adapt to lower estrogen after menopause —unless they have a history of major depressive disorder, Vanderbilt researchers have found. -
August 5, 2021
NIMH support bolsters early psychosis research efforts
The Department of Psychiatry and Behavioral Sciences has received an additional $4 million from the National Institute of Mental Health (NIMH) to study the evolution of hippocampal dysfunction in the early stage of psychosis. -
July 27, 2021
Pawlikowski named president of Vanderbilt Psychiatric Hospital
Mary Pawlikowski, MA, MEd, interim vice president and chief operating officer for Vanderbilt Psychiatric Hospital (VPH), has been named as the hospital’s new president after having held the position of president on an interim basis since November 2020. -
July 26, 2021
Mood and cognition after chemotherapy
Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report. -
July 22, 2021
Resident’s opioid-related efforts become TMA priority
Leah Jesse, MD, a Psychiatry resident, successfully brought an anti-stigma resolution to the floor of the Tennessee Medical Association (TMA) House of Delegates meeting in May. -
April 29, 2021
Program combines treatment for mental health, substance use disorders
For people with co-occurring mental health disorders and substance use disorders, finding integrated care that treats both conditions can be a difficult task. Vanderbilt Behavioral Health is seeking to simplify care for these patients through the co-occurring disorders intensive outpatient program (IOP).